Physician profile
Brion Winston
NPI 1932201159
$105,285.18
in general payments reported to CMS, 2019-2025
29 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $42K · 2021: $913 · 2022: $1,348 · 2023: $1,766 · 2024: $14K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $5,768 · Travel and Lodging: $4,116 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,866.00 |
| Food and Beverage | $5,768.44 |
| Travel and Lodging | $4,115.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Education | $100.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $72,460.23 | 2019-2025 | General - Therapies, Versacross Access Solution, Baylis Medical Company Radiofrequency Puncture Generator |
| Angiodynamics, INC. | $15,167.37 | 2023-2025 | Alphavac, Angiovac |
| Edwards Lifesciences Corporation | $11,245.95 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Inari Medical, INC. | $2,500.00 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $1,121.98 | 2019-2025 | Mitraclip, Navitor, Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $653.26 | 2019-2025 | |
| Pfizer INC. | $301.82 | 2019-2024 | |
| Amgen INC. | $283.09 | 2019-2025 | Repatha, Repatha |
| W. L. Gore & Associates, INC. | $216.73 | 2024 | Gore Cardioform Septal Occluder |
| Janssen Pharmaceuticals, INC | $214.10 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $191.87 | 2019-2024 | Camzyos, Eliquis |
| Abiomed | $189.24 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.50 | 2019 | |
| Chiesi USA, INC. | $141.61 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $79.92 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $60.89 | 2019-2022 | |
| Gilead Sciences, INC. | $38.86 | 2019 | |
| Esperion Therapeutics, INC. | $38.27 | 2021-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $37.17 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $36.27 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals, Ltd. | $25.92 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $21.24 | 2019 | |
| Novo Nordisk INC | $19.95 | 2025 | |
| Alnylam Pharmaceuticals INC. | $18.21 | 2025 | Onpattro |
| Scpharmaceuticals INC. | $17.62 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $14.45 | 2024 | Arcalyst |
| B. Braun Interventional Systems INC. | $12.97 | 2023 | No Marketed Product Name |
| Merck Sharp & Dohme LLC | $12.89 | 2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brion Winston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.